Privacy·Terms·Disclaimer

Bibliographic data courtesy of the U.S. National Library of Medicine (NLM), sourced from PubMed/MEDLINE.

SciRadar is not affiliated with, endorsed by, or sponsored by NLM or NCBI. Abstracts remain © their respective publishers.

Tislelizumab plus lenvatinib in unresectable locally advanced biliary tract cancer. — SciRadar

Back to results

Journal of cancer research and therapeutics

Tislelizumab plus lenvatinib in unresectable locally advanced biliary tract cancer.

Bhoor S Bhati, Ajay Gogia, Surender Saini

Published: 202510.4103/jcrt.jcrt_2053_25

No abstract available for this study.